Imperva (IMPV) Downgraded to “Hold” at Zacks Investment Research
Zacks Investment Research downgraded shares of Imperva (NASDAQ:IMPV) from a buy rating to a hold rating in a research note published on Wednesday.
According to Zacks, “Imperva Inc. is engaged in the development of protection software and services for business applications and databases. The Company delivers innovative technology to give full audit accountability and separation of duties to meet regulatory compliance. It offers SecureSphere Data Security Suite to protect sensitive data from hackers and malicious insiders along with providing a fast and cost-effective route to regulatory compliance and establishes a repeatable process for data risk management. The Company’s SecureSphere offers database security solutions to secure sensitive data stored in databases, File Security solutions to protect sensitive files on file servers, storage devices, content repositories, and meet regulatory compliance mandates and Web Application Security solutions to protect web applications from cyber attacks. Imperva Inc. is headquartered in Redwood Shores, California. “
IMPV has been the subject of a number of other reports. Piper Jaffray Companies reiterated a neutral rating and set a $58.00 price target on shares of Imperva in a report on Friday, October 13th. JPMorgan Chase & Co. lowered shares of Imperva from a neutral rating to an underweight rating and set a $45.00 price target for the company. in a report on Tuesday, December 12th. BidaskClub upgraded shares of Imperva from a sell rating to a hold rating in a report on Tuesday, September 12th. KeyCorp reiterated a hold rating on shares of Imperva in a report on Tuesday, October 24th. Finally, Evercore ISI reiterated a buy rating and set a $56.00 price target on shares of Imperva in a report on Wednesday, November 8th. Three analysts have rated the stock with a sell rating, eight have issued a hold rating and nine have assigned a buy rating to the company’s stock. The company presently has an average rating of Hold and an average target price of $51.86.
Imperva (NASDAQ:IMPV) last posted its quarterly earnings results on Wednesday, November 8th. The software maker reported $0.33 EPS for the quarter, beating the Zacks’ consensus estimate of $0.22 by $0.11. Imperva had a net margin of 3.04% and a negative return on equity of 8.52%. The company had revenue of $83.89 million during the quarter, compared to analyst estimates of $83.79 million. During the same period in the prior year, the business posted $0.08 EPS. The firm’s revenue was up 22.6% compared to the same quarter last year. analysts expect that Imperva will post -0.52 EPS for the current fiscal year.
A number of hedge funds and other institutional investors have recently modified their holdings of the business. Vanguard Group Inc. raised its holdings in Imperva by 4.3% in the 2nd quarter. Vanguard Group Inc. now owns 2,439,240 shares of the software maker’s stock worth $116,718,000 after purchasing an additional 99,799 shares in the last quarter. BlackRock Inc. raised its holdings in Imperva by 11.3% in the 2nd quarter. BlackRock Inc. now owns 2,124,043 shares of the software maker’s stock worth $101,635,000 after purchasing an additional 215,170 shares in the last quarter. Eagle Asset Management Inc. raised its holdings in Imperva by 1.2% in the 3rd quarter. Eagle Asset Management Inc. now owns 1,294,651 shares of the software maker’s stock worth $55,928,000 after purchasing an additional 14,803 shares in the last quarter. Alyeska Investment Group L.P. raised its holdings in Imperva by 89.3% in the 3rd quarter. Alyeska Investment Group L.P. now owns 907,615 shares of the software maker’s stock worth $39,390,000 after purchasing an additional 428,163 shares in the last quarter. Finally, ETF Managers Group LLC bought a new position in Imperva in the 2nd quarter worth $41,888,000. Institutional investors and hedge funds own 96.93% of the company’s stock.
TRADEMARK VIOLATION WARNING: This story was published by Watch List News and is owned by of Watch List News. If you are reading this story on another domain, it was illegally copied and republished in violation of United States & international trademark and copyright legislation. The correct version of this story can be accessed at https://www.watchlistnews.com/imperva-impv-downgraded-to-hold-at-zacks-investment-research/1803512.html.
Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Imperva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva and related companies with MarketBeat.com's FREE daily email newsletter.